Nathalie Pansu

Nathalie Pansu

Auto-generated profile, based on publicly available information

Nathalie Pansu

Department of Tropical and Infectious Diseases, Montpellier University Hospital , Montpellier

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2020 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
ECEvangéline CLARK
Evangéline CLARK
PGPhilippe Guilpain
Philippe Guilpain
IFIonut Laurentiu Filip
Ionut Laurentiu Filip
NPNathalie Pansu
Nathalie Pansu
CBClément Le Bihan
Clément Le Bihan
VMVincent Le Moing
Vincent Le Moing
We read with deep interest the report by Tepasse and colleagues1 , concerning two cases of persisting viremia in Covid‐19 with fatal outcome. Whilst SARS‐CoV‐2 infection in the early stages of infection has been well described, less is known about the development of antibodies to SARS‐CoV‐2, clearance of RNA shedding and clinical outcome of COVID‐19.

14 October 2023 in Chest
Verified
Journal Article
Closed access
GTGuillaume Thizy
Guillaume Thizy
AFAdrien Flahault
Adrien Flahault
ASAnne Scemla
Anne Scemla
OROlivier Roux
Olivier Roux
SJSophie Jarraud
Sophie Jarraud
ELEMMANUEL Lafont
EMMANUEL Lafont

1 November 2020 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
NPN. Pansu
N. Pansu
MHM. Hamoui
M. Hamoui
FMF. Manna
F. Manna
AMA. Makinson
A. Makinson
SDS. Dufour
S. Dufour
VMV. Le Moing
V. Le Moing

30 August 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
FCF Coustilleres
F Coustilleres
ETE M Thillard
E M Thillard
RKR K Khanna
R K Khanna
SOS Olivereau
S Olivereau
MOM Ouaissi
M Ouaissi
MLM L Le Lez
M L Le Lez
The long-term tolerability of linezolid is low because of mitochondrial toxicity, whereas tedizolid may represent a better option for suppressive therapy. We report a first presumed case of tedizolid-associated optic neuropathy after a very prolonged (18-month) intake and believe that screening for optic neuropathy should be considered for patients undergoing tedizolid suppression.

2 March 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
NPNathalie Pansu
Nathalie Pansu
VMVincent Le Moing
Vincent Le Moing
IPIsabelle Poizot-Martin
Isabelle Poizot-Martin
VJVéronique Joly
Véronique Joly
CAClotilde Allavena
Clotilde Allavena
AMAlain Makinson
Alain Makinson

30 November 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
CFCelia François
Celia François
CMCelia Martinez
Celia Martinez
CFClement Faye
Clement Faye
NPNathalie Pansu
Nathalie Pansu
CDCatherine Dunyach-Remy
Catherine Dunyach-Remy
ACAxelle Cadiere
Axelle Cadiere
Molecular approaches are powerful tools that are used for medical or environmental diagnoses. However, the main limitations of such a tools are that they extract low levels of DNA and they do not remove the inhibitors of polymerase chain reaction (PCR). Although the use of polycation to complex and purify DNA has been described in the literature, elution often requires a high ionic strength or pH levels not compatible with molecular analyses. In this paper, we described a new process that is based on the complexation of DNA with linear polylysine, followed by capturing the complex by a cation exchange resin. The originality of the process consisted of using mechanic force to elute DNA from the complex. The extraction method showed several advantages when compared to existing methods, such as being compatible with pH levels that range from 5 to 11, as well as high levels of DNA recovery and elimination of PCR inhibitors from complex samples. This method was successfully applied to different types of samples, such as environmental samples, beverage samples, and medical samples. Furthermore, it was proven to be a good solution for removing PCR inhibitors and assuring good DNA recovery yield.